JNC 8 Guidelines Update

http://www.medscape.com/viewarticle/817991

Nine Recommendations
Those questions then form the basis for nine recommendations, discussed in depth and assigned a score for both the strength of the recommendation and the evidence supporting it. Among the recommendations:

• In patients 60 years or over, start treatment in blood pressures >150 mm Hg systolic or >90 mm Hg diastolic and treat to under those thresholds.
• In patients <60 140="" and="" be="" goals="" hg="" in="" initiation="" mm="" patients="" same="" should="" the="" threshold="" treatment="" u="" used="" years="">>

18 years with either chronic kidney disease (CKD) or diabetes.

In nonblack patients with hypertension, initial treatment can be a thiazide-type diuretic, CCB, ACE inhibitor, or ARB, while in the general black population, initial therapy should be a thiazide-type diuretic or CCB.

In patients >18 years with CKD, initial or add-on therapy should be an ACE inhibitor or ARB, regardless of race or diabetes status.